CBP EVOLUTION
ActiveSummary
CBP EVOLUTION has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €94,438 and a net result of €37,710. Equity is growing by ~37.9% per year across the filed fiscal years. The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2024
Axes · tick = 2023
Profitability92▼-8
Solvency72▼-28
Growth52=
Track record100
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €7,000 at 30 days acceptable
Liquidity ample (current ratio 1.67 against 7.75 in 2023; short-term debt: 38.3% and cash: 12.5% of total assets), but 53.4% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-06-2026, 47 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
47 d early
2024
20 d late
2023
70 d early
2022
31 d late
2021
31 d late
2020
26 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 2 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 20 August (4 of the last 5 filed years within 67 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, micro schema
Turnover
€124,231▲ 2.9%
2021 · €120,743
EBIT margin
28.0%▲ 8.9pp
2021 · 19.1%
Net result
€37,710▲ 10.2%
2023 · €34,227
Working capital
€52,123▼ 47.4%
2023 · €99,171
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Turnover€368,615-€120,743▼ 67.2%€124,231▲ 2.9%
Operating result€38,751-€23,102▼ 40.4%€34,769▲ 50.5%€37,287▲ 7.2%€54,829▲ 47.0%
Net result€30,300within the sector's middle half-€16,094below the sector's middle half▼ 46.9%€25,627within the sector's middle half▲ 59.2%€34,227within the sector's middle half▲ 33.6%€37,710within the sector's middle half▲ 10.2%
EBIT margin10.5%-19.1%▲ 8.6pp28.0%▲ 8.9pp
Equity€38,380below the sector's middle half-€53,674below the sector's middle half▲ 39.8%€78,501within the sector's middle half▲ 46.3%€106,728within the sector's middle half▲ 36.0%€94,438within the sector's middle half▼ 11.5%
Total assets€259,804within the sector's middle half-€63,375below the sector's middle half▼ 75.6%€96,353below the sector's middle half▲ 52.0%€122,675below the sector's middle half▲ 27.3%€202,782within the sector's middle half▲ 65.3%
Debt€221,424-€9,701▼ 95.6%€17,852▲ 84.0%€15,947▼ 10.7%€108,344▲ 579%
Working capital-€49,951below the sector's middle half-€47,728within the sector's middle half€72,014within the sector's middle half▲ 50.9%€99,171within the sector's middle half▲ 37.7%€52,123within the sector's middle half▼ 47.4%
Solvency14.8%below the sector's middle half-84.7%above the sector's middle half▲ 69.9pp81.5%within the sector's middle half▼ 3.2pp87.0%above the sector's middle half▲ 5.5pp46.6%within the sector's middle half▼ 40.4pp
Current ratio0.77below the sector's middle half-5.92within the sector's middle half▲ 5.155.88within the sector's middle half▼ 0.047.75above the sector's middle half▲ 1.871.67within the sector's middle half▼ 6.08
Return on assets (ROA)11.7%within the sector's middle half-25.4%within the sector's middle half▲ 13.7pp26.6%within the sector's middle half▲ 1.2pp27.9%within the sector's middle half▲ 1.3pp18.6%within the sector's middle half▼ 9.3pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2021 the operating result has climbed three years in a row; 2024 is 47% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €202,782
Fixed assets
€72,984 ▲ 728%
Current assets
€129,798 ▲ 14.0%
Equity and liabilities €202,782
Equity
€94,438 ▼ 11.5%
Debt
€108,344 ▲ 579%
Debt's share of the balance-sheet total rises from 13.0% to 53.4%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€61,108▲
2023 · €41,239
Cash flow
€43,989▲
2023 · €38,179
Debt to equity
1.15▲
2023 · 0.15
ROE
39.9%▲
2023 · 32.1%
Interest coverage
15.91▼
2023 · 17.25
Debt ≤ 1 year
€77,675▲
2023 · €14,690
Debt > 1 year
€29,686▲
2023 · €1,257
Income taxes
€13,278▲
2023 · €8,902
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 26,975 companies that looked in July 2024 the way this one looks now, 1.6% went bankrupt within 24 months and 95% are still going.
- Micro
- 5 to 10 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
1.6%
went bankrupt
3.4%
stopped otherwise
95%
still going
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.2% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.9% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 26,975 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Turnover70 | €368,615 | €120,743 | €124,231 | - | - | - |
| Goods, raw materials, services and sundry goods60/61 | - | €90,661 | €87,547 | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €29,009 | €2,886 | €3,827 | €3,952 | €6,279 | ▲ 58.9% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | - | - | - | €1,170 | €709 | ▼ 39.4% |
| Other operating charges640/8 | - | €5,258 | €644 | €11,979 | €7,878 | ▼ 34.2% |
| Gross operating margin9900 | €74,435 | €31,246 | €39,240 | €54,388 | €69,695 | ▲ 28.1% |
| Operating profit (loss)9901 | €38,751 | €23,102 | €34,769 | €37,287 | €54,829 | ▲ 47.0% |
| Financial income75/76B | - | - | €1 | €8,232 | - | - |
| Recurring financial income75 | €1,041 | - | €1 | €8,232 | - | - |
| Financial charges65/66B | - | €2,088 | €2,974 | €2,390 | €3,841 | ▲ 60.7% |
| Recurring financial charges65 | €249 | €2,088 | €2,974 | €2,390 | €3,841 | ▲ 60.7% |
| Profit (loss) for the period before taxes9903 | €39,543 | €21,014 | €31,796 | €43,129 | €50,988 | ▲ 18.2% |
| Income taxes67/77 | €9,243 | €4,920 | €6,169 | €8,902 | €13,278 | ▲ 49.2% |
| Profit (loss) for the period9904 | €30,300 | €16,094 | €25,627 | €34,227 | €37,710 | ▲ 10.2% |
| Profit (loss) for the period to be appropriated9905 | €30,300 | €16,094 | €25,627 | €34,227 | €37,710 | ▲ 10.2% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €259,804 | €63,375 | €96,353 | €122,675 | €202,782 | ▲ 65.3% |
| Fixed assets21/28 | €88,331 | €5,946 | €9,583 | €8,814 | €72,984 | ▲ 728% |
| Tangible fixed assets22/27 | €88,331 | €5,946 | €9,583 | €8,814 | €72,984 | ▲ 728% |
| Land and buildings22 | - | - | - | - | €50,107 | - |
| Plant, machinery and equipment23 | - | - | €4,980 | €3,887 | €19,937 | ▲ 413% |
| Furniture and vehicles24 | - | €5,946 | €4,603 | €4,927 | €2,940 | ▼ 40.3% |
| Current assets29/58 | €171,473 | €57,429 | €86,770 | €113,861 | €129,798 | ▲ 14.0% |
| Stocks and contracts in progress3 | €7,701 | - | - | - | - | - |
| Amounts receivable within one year40/41 | €138,942 | €18,388 | €22,806 | €34,982 | €102,868 | ▲ 194% |
| Trade receivables40 | - | €15,736 | €15,193 | €30,708 | €42,868 | ▲ 39.6% |
| Other amounts receivable41 | - | €2,652 | €7,613 | €4,274 | €60,000 | ▲ 1,304% |
| Current investments50/53 | - | - | €29,750 | - | - | - |
| Cash at bank and in hand54/58 | €24,712 | €37,539 | €32,712 | €77,071 | €25,428 | ▼ 67.0% |
| Deferred charges and accrued income490/1 | - | €1,502 | €1,502 | €1,808 | €1,502 | ▼ 16.9% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €259,804 | €63,375 | €96,353 | €122,675 | €202,782 | ▲ 65.3% |
| Equity10/15 | €38,380 | €53,674 | €78,501 | €106,728 | €94,438 | ▼ 11.5% |
| Contributions10/11 | €8,080 | €8,080 | €8,080 | €8,080 | €8,080 | = |
| Outside capital11 | - | €8,080 | €8,080 | €8,080 | - | - |
| Share premium1100/10 | - | €8,080 | €8,080 | €8,080 | - | - |
| Profit (loss) carried forward14 | €30,300 | €45,594 | €70,421 | €98,648 | €86,358 | ▼ 12.5% |
| Amounts payable17/49 | €221,424 | €9,701 | €17,852 | €15,947 | €108,344 | ▲ 579% |
| Amounts payable after more than one year17 | - | - | €3,096 | €1,257 | €29,686 | ▲ 2,262% |
| Financial debts170/4 | - | - | €3,096 | €1,257 | €29,686 | ▲ 2,262% |
| Amounts payable within one year42/48 | €221,424 | €9,701 | €14,756 | €14,690 | €77,675 | ▲ 429% |
| Current portion of amounts payable after more than one year42 | - | - | €1,783 | €2,672 | €10,793 | ▲ 304% |
| Trade debts44 | €111,620 | €2,581 | €2,045 | €3,679 | €1,336 | ▼ 63.7% |
| Suppliers440/4 | - | €2,581 | €2,045 | €3,679 | €1,336 | ▼ 63.7% |
| Taxes, remuneration and social security45 | - | €6,320 | €962 | €2,339 | €13,768 | ▲ 489% |
| Taxes450/3 | - | €6,320 | €962 | €2,339 | €13,768 | ▲ 489% |
| Other amounts payable47/48 | - | €800 | €9,966 | €6,000 | €51,778 | ▲ 763% |
| Accrued charges and deferred income492/3 | - | - | - | - | €983 | - |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €30,300 | €16,094 | €25,627 | €34,227 | €37,710 | ▲ 10.2% |
| + Depreciation and write-downs630 | €29,009 | €2,886 | €3,827 | €3,952 | €6,279 | ▲ 58.9% |
| Operating cash flow (approximation) | €59,309 | €18,980 | €29,454 | €38,179 | €43,989 | ▲ 15.2% |
| Investment in fixed assets (approximation) | - | €79,499 | -€7,464 | -€3,183 | -€70,449 | ▼ 2,113% |
| Change in cash | - | €12,827 | -€4,827 | €44,359 | -€51,643 | ▼ 216% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
14-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
20-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 20 days late
2024
31-12
Financial
Highest result since 2020net €37,710 ▲10.2%
Operating result €54,829, net result €37,710, both a record.
22-05
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Equity above €100,000Eq €106,728 ▲36%
4 profitable years in a row build equity to €106,728.
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
2022
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
31-12
Financial
Weakest financial yearnet €16,094 ▼46.9%
Net result drops to €16,094, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity times 8current ratio 5.92
Current ratio from 0.77 to 5.92; short-term debt falls from €221,424 to €9,701.
26-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 26 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Nivelles
Ground area
503 m²
Building footprint
110 m²
Volume, LiDAR
554 m³
Parcel 25004E0174/00Y011, Wallonia · tallest building 7.1 m, ±2 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25004E0174/00Y011 | Wallonia | 503 m² | 1 · 110 m² | 7.1 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
875500HGWBNXW85HQ431
Similar companies · same sector, comparable size
ReMOOV
BE 0775.785.610
Beveren-Kruibeke-Zwijndrecht · Eq €94,457
B-STRONG
BE 0795.535.305
Lievegem · Eq €94,646
Kinepraktijk Ruggeveld
BE 0740.801.668
Antwerpen · Eq €94,167
JVR
BE 0736.906.129
Heist-op-den-Berg · Eq €94,726
ZENITH
BE 0874.982.956
Zonhoven · Eq €94,128
Of 12,698 companies in sector 86951 we hold annual accounts for 2,146. 1,879 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded18-03-2019
Fiscal year end31-12
Activities, NACEBEL 2025
86951Physiotherapy
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
E-invoicing
Reachable via Peppol
Peppol ID
0208:0722882107
Registered
27-03-2026
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.